Mixed results for Nexalin’s transcranial alternating current stimulation trial
Nexalin’s device missed the primary endpoint but produced positive data in secondary endpoint measures.
Medical Devices
Adaptive deep brain stimulation trial results poised to “transform” Parkinson’s disease
SetPoint’s neuromodulation implant wins IDE for multiple sclerosis study
Synchron’s BCI meets primary endpoint in feasibility trial
Wesper sleep platform reduces nerve stimulation titration time by 45%
Bridge to Life bolsters efficacy data for HOPE perfusion device in liver transplant
Synergia implants first patients with neurostimulator for epilepsy treatment
Onward implants second patient with brain chip in spinal cord injury trial
